Cargando…

In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample

BACKGROUND: Acute myocardial infarction (AMI) with essential thrombocythemia (ET) or polycythemia vera is rare, and there are scarce real‐world data on its management and impact on in‐hospital outcomes. METHODS AND RESULTS: Dates of current retrospective cohort study were obtained from the US Nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jing, Fan, YongZhen, Zhao, Wei, Li, Bing, Pan, Naifan, Lou, Zhiyang, Zhang, Mingyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798805/
https://www.ncbi.nlm.nih.gov/pubmed/36515250
http://dx.doi.org/10.1161/JAHA.122.027352
_version_ 1784860983395614720
author Wu, Jing
Fan, YongZhen
Zhao, Wei
Li, Bing
Pan, Naifan
Lou, Zhiyang
Zhang, Mingyou
author_facet Wu, Jing
Fan, YongZhen
Zhao, Wei
Li, Bing
Pan, Naifan
Lou, Zhiyang
Zhang, Mingyou
author_sort Wu, Jing
collection PubMed
description BACKGROUND: Acute myocardial infarction (AMI) with essential thrombocythemia (ET) or polycythemia vera is rare, and there are scarce real‐world data on its management and impact on in‐hospital outcomes. METHODS AND RESULTS: Dates of current retrospective cohort study were obtained from the US National Inpatient Sample from October 2015 to 2019 for hospitalizations with AMI. The primary outcome was in‐hospital mortality, and the secondary outcome was major adverse cardiac or cerebrovascular events, stroke, and bleeding; major adverse cardiac or cerebrovascular event was defined by a composite of all‐cause mortality, stroke, and cardiac complications. Of the 2 871 934 weighted AMI hospitalizations, 0.27% were with ET and 0.1% were with polycythemia vera. Before propensity matching, AMI hospitalization with ET was associated with increased risk of in‐hospital mortality (7.1% versus 5.7%; odds ratio [OR], 1.14 [95% CI, 1.04–1.24]), major adverse cardiac or cerebrovascular events (12.6% versus 9%; OR, 1.36 [95% CI, 1.26–1.45]), bleeding (12.7% versus 5.8%; OR, 2.28 [95% CI, 2.13–2.44]), and stroke (3.1% versus 1.8%; OR, 1.66 [95% CI, 1.46–1.89]). Polycythemia vera was associated with an increased risk of in‐hospital mortality (7.8% versus 5.7%; OR, 1.21 [95% CI, 1.04–1.39]) and major adverse cardiac or cerebrovascular events (12.0% versus 9%; OR, 1.18 [95% CI, 1.05–1.33]). After propensity matching, ET was associated with increased risk of bleeding (12.6% versus 6.1%; OR, 2.22 [95% CI, 1.70–2.90]), and AMI with polycythemia vera was not associated with worse in‐hospital outcomes. CONCLUSIONS: AMI hospitalization with ET is associated with high bleeding risk before and after propensity score matching, particularly for hospitalizations treated with percutaneous coronary intervention. The management of AMI requires a multidisciplinary and patient‐centered approach to ensure safety and improve outcomes.
format Online
Article
Text
id pubmed-9798805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97988052023-01-05 In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample Wu, Jing Fan, YongZhen Zhao, Wei Li, Bing Pan, Naifan Lou, Zhiyang Zhang, Mingyou J Am Heart Assoc Original Research BACKGROUND: Acute myocardial infarction (AMI) with essential thrombocythemia (ET) or polycythemia vera is rare, and there are scarce real‐world data on its management and impact on in‐hospital outcomes. METHODS AND RESULTS: Dates of current retrospective cohort study were obtained from the US National Inpatient Sample from October 2015 to 2019 for hospitalizations with AMI. The primary outcome was in‐hospital mortality, and the secondary outcome was major adverse cardiac or cerebrovascular events, stroke, and bleeding; major adverse cardiac or cerebrovascular event was defined by a composite of all‐cause mortality, stroke, and cardiac complications. Of the 2 871 934 weighted AMI hospitalizations, 0.27% were with ET and 0.1% were with polycythemia vera. Before propensity matching, AMI hospitalization with ET was associated with increased risk of in‐hospital mortality (7.1% versus 5.7%; odds ratio [OR], 1.14 [95% CI, 1.04–1.24]), major adverse cardiac or cerebrovascular events (12.6% versus 9%; OR, 1.36 [95% CI, 1.26–1.45]), bleeding (12.7% versus 5.8%; OR, 2.28 [95% CI, 2.13–2.44]), and stroke (3.1% versus 1.8%; OR, 1.66 [95% CI, 1.46–1.89]). Polycythemia vera was associated with an increased risk of in‐hospital mortality (7.8% versus 5.7%; OR, 1.21 [95% CI, 1.04–1.39]) and major adverse cardiac or cerebrovascular events (12.0% versus 9%; OR, 1.18 [95% CI, 1.05–1.33]). After propensity matching, ET was associated with increased risk of bleeding (12.6% versus 6.1%; OR, 2.22 [95% CI, 1.70–2.90]), and AMI with polycythemia vera was not associated with worse in‐hospital outcomes. CONCLUSIONS: AMI hospitalization with ET is associated with high bleeding risk before and after propensity score matching, particularly for hospitalizations treated with percutaneous coronary intervention. The management of AMI requires a multidisciplinary and patient‐centered approach to ensure safety and improve outcomes. John Wiley and Sons Inc. 2022-12-14 /pmc/articles/PMC9798805/ /pubmed/36515250 http://dx.doi.org/10.1161/JAHA.122.027352 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Wu, Jing
Fan, YongZhen
Zhao, Wei
Li, Bing
Pan, Naifan
Lou, Zhiyang
Zhang, Mingyou
In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample
title In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample
title_full In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample
title_fullStr In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample
title_full_unstemmed In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample
title_short In‐Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample
title_sort in‐hospital outcomes of acute myocardial infarction with essential thrombocythemia and polycythemia vera: insights from the national inpatient sample
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798805/
https://www.ncbi.nlm.nih.gov/pubmed/36515250
http://dx.doi.org/10.1161/JAHA.122.027352
work_keys_str_mv AT wujing inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample
AT fanyongzhen inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample
AT zhaowei inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample
AT libing inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample
AT pannaifan inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample
AT louzhiyang inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample
AT zhangmingyou inhospitaloutcomesofacutemyocardialinfarctionwithessentialthrombocythemiaandpolycythemiaverainsightsfromthenationalinpatientsample